Lv5
986 积分 2023-08-26 加入
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024
1小时前
待确认
A challenging frontier – the genomics and therapeutics of nonclear cell renal cell carcinoma
1小时前
求助中
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates
6天前
已完结
Renal cell carcinoma
6天前
已完结
Parenchymal Mass Preserved after Partial Nephrectomy and “Global Renal Damage”: Two Faces of the Same Coin
13天前
已完结
Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U
13天前
已完结
Predicting recurrence in patients with localised renal cell carcinoma after nephrectomy
15天前
已完结
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling
24天前
已完结
Basal Cell Carcinoma and Squamous Cell Carcinoma: Recognition and Treatment
24天前
已完结
Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings
1个月前
已完结
皖公网安备34019202002308
